PRUDENTIAL FINANCIAL INC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 158 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
PRUDENTIAL FINANCIAL INC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$43,132
-25.5%
16,4000.0%0.00%
Q2 2023$57,892
+14.2%
16,4000.0%0.00%
Q1 2023$50,676
+13.0%
16,400
+54.7%
0.00%
Q4 2022$44,838
-91.7%
10,600
-94.3%
0.00%
-100.0%
Q1 2022$539,000
-0.7%
186,936
+4.8%
0.00%0.0%
Q4 2021$543,000
-78.5%
178,436
-50.4%
0.00%
-75.0%
Q3 2021$2,521,000
-28.6%
359,695
-6.5%
0.00%
-20.0%
Q2 2021$3,531,000
+41.4%
384,737
+49.8%
0.01%
+25.0%
Q1 2021$2,497,000
-14.3%
256,884
-9.6%
0.00%
-20.0%
Q4 2020$2,915,000
-16.6%
284,121
-18.0%
0.01%
-28.6%
Q3 2020$3,497,000
+227.7%
346,521
+238.8%
0.01%
+250.0%
Q2 2020$1,067,000
+413.0%
102,281
+2813.2%
0.00%
Q2 2018$208,000
-12.6%
3,511
+0.6%
0.00%
Q1 2018$238,000
-29.4%
3,491
+2.3%
0.00%
Q4 2017$337,000
-20.3%
3,411
-3.4%
0.00%
-100.0%
Q3 2017$423,000
+40.1%
3,531
+2.2%
0.00%
Q2 2017$302,000
+50.2%
3,455
+15.2%
0.00%
Q3 2016$201,000
-69.7%
3,000
+6.8%
0.00%
-100.0%
Q1 2015$663,000
+24.6%
2,8100.0%0.00%0.0%
Q4 2014$532,000
-23.3%
2,810
-3.4%
0.00%0.0%
Q3 2014$694,000
+87.6%
2,910
-48.0%
0.00%0.0%
Q2 2014$370,000
+23.3%
5,600
+94.4%
0.00%0.0%
Q1 2014$300,000
+1.4%
2,880
+0.7%
0.00%0.0%
Q4 2013$296,0002,8600.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q3 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders